WHO monographs on selected medicinal plants - travolekar.ru
Share Embed Flag
Download ePaper

WHO monographs on selected medicinal plants - travolekar.ru

WHO monographs on selected medicinal plants - travolekar.ru WHO monographs on selected medicinal plants - travolekar.ru

ucg.ac.me
20.01.2015 Views

ong>WHOong> ong>monographsong> on selected medicinal plants 39. Cuéllar MJ et al. Topical anti-inflammatory activity of some Asian medicinal plants used in dermatological disorders. Fitoterapia, 2001, 72:221–229. 40. Otsuka H et al. Studies on anti-inflammatory agents. II. Anti-inflammatory constituents from rhizome of Coptis japonica Makino. Yakugaku Zasshi, 1981, 101:883–890. 41. Zhou H, Mineshita S. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. Journal of Pharmacology and Experimental Therapeutics, 2000, 294:822–829. 42. Iizuka N et al. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Letters, 2000, 148:19–25. 43. Yang HC, Chang HH, Weng TC. Influence of several Chinese drugs on the growth of some pathologic organisms: preliminary report. Journal of the Formosan Medical Association, 1953, 52:109–112. 44. Namba T et al. Studies on dental caries prevention by traditional Chinese medicines (Part 1). Screening of crude drugs for antibacterial action against Streptococcus mutans. Shoyakugaku Zasshi, 1981, 35:295–302. 45. Nakamoto K, Sadamori S, Hamada T. Effects of crude drugs and berberine hydrochloride on the activities of fungi. Journal of Prosthetic Dentistry, 1990, 64:691–694. 46. Mahady GB et al. In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis. Phytotherapy Research, 2003, 17:217–221. 47. Bae EA et al. Anti-Helicobacter pylori activity of herbal medicines. Biological and Pharmaceutical Bulletin, 1998, 21:990–992. 48. Chi HJ, Woo YS, Lee YJ. [Effect of berberine and some antibiotics on the growth of microorganisms.] [Korean Journal of Pharmacognosy], 1991, 22:45–50 [in Korean]. 49. Gentry EJ et al. Antitubercular natural products: berberine from the roots of commercial Hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, -hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and -2. Journal of Natural Products, 1998, 61:1187–1193. 50. Iwasa K et al. Structure-activity relationships of protoberberines having antimicrobial activity. Planta Medica, 1998, 64:748–751. 51. Kaneda Y et al. In vitro effects of berberine sulfate on the growth and structure of Entamoeba histolytica, Giardia lamblia, and Trichomonas vaginalis. Annals of Tropical Medicine and Parasitology, 1991, 85:417–425. 52. Schinella GR et al. Inhibition of Trypanosoma cruzi growth by medicinal plant extracts. Fitoterapia, 2002, 73:569–575. 53. Takase H et al. Features of the anti-ulcer effects of Oren-Gedoku-to (a Traditional Chinese Medicine) and its component herb drugs. Japanese Journal of Pharmacology, 1989, 49:301–308. 54. Wong KK. Mechanism of the aorta relaxation induced by low concentrations of berberine. Planta Medica, 1998, 64:756–757. 256

Cortex Phellodendron 55. Chiou WF, Yen MH, Chen CF. Mechanism of vasodilatory effect of berberine in rat mesenteric artery. European Journal of Pharmacology, 1991, 204:35–40. 56. Ko WH et al. Vasorelaxant and antiproliferative effects of berberine. European Journal of Pharmacology, 2000, 399:187–196. 57. Chiou WF, Chen J, Chen CF. Relaxation of corpus cavernosum and raised intracavernous pressure by berberine in rabbit. British Journal of Pharmacology, 1998, 125:1677–1684. 58. Mori H et al. Principle of the bark of Phellodendron amurense to suppress the cellular immune response. Planta Medica, 1994, 60:445–449. 59. Mori H et al. Principle of the bark of Phellodendron amurense to suppress the cellular immune response: effect of phellodendrine on cellular and humoral immune responses. Planta Medica, 1995, 61:45–49. 60. Marinova EK et al. Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine. Immunopharmacology, 2000, 48:9–16. 61. Lampe KF. Berberine. In: De Smet PA et al. eds. Adverse effects of herbal drugs. Vol. 1. Berlin, Springer-Verlag, 1992:97–104. 62. Lin HL et al. Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells. Cancer, 1999, 85:1937– 1942. 63. Lin HL et al. Berberine modulates expression of mdr1 gene products and the responses of digestive tract cancer cells to Paclitaxel. British Journal of Cancer, 1999, 81:416–422. 64. Wu XC, et al. Effects of berberine on the blood concentration of cyclosporin A in renal transplant recipients: clinical and pharmacokinetic study. European Journal of Clinical Pharmacology, 2005, 61:567–572. 65. Budzinski JW et al. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine, 2000, 7:273–282. 66. Morimoto I et al. Mutagenicity screening of crude drugs with Bacillus subtillus rec-assay and Salmonella/microsome reversion assay. Mutation Research, 1982, 97:81–102. 67. Pasqual MS et al. Genotoxicity of the isoquinoline alkaloid berberine in prokaryotic and eukaryotic organisms. Mutation Research, 1993, 286:243–252. 68. Lee EB. [Teratogenicity of the extracts of crude drugs.] [ Korean Journal of Pharmacognosy], 1982, 13:116–121 [in Korean]. 257

Cortex Phellodendr<strong>on</strong><br />

55. Chiou WF, Yen MH, Chen CF. Mechanism of vasodilatory effect of berberine<br />

in rat mesenteric artery. European Journal of Pharmacology, 1991,<br />

204:35–40.<br />

56. Ko WH et al. Vasorelaxant and antiproliferative effects of berberine. European<br />

Journal of Pharmacology, 2000, 399:187–196.<br />

57. Chiou WF, Chen J, Chen CF. Relaxati<strong>on</strong> of corpus cavernosum and raised<br />

intracavernous pressure by berberine in rabbit. British Journal of Pharmacology,<br />

1998, 125:1677–1684.<br />

58. Mori H et al. Principle of the bark of Phellodendr<strong>on</strong> amurense to suppress<br />

the cellular immune resp<strong>on</strong>se. Planta Medica, 1994, 60:445–449.<br />

59. Mori H et al. Principle of the bark of Phellodendr<strong>on</strong> amurense to suppress<br />

the cellular immune resp<strong>on</strong>se: effect of phellodendrine <strong>on</strong> cellular and humoral<br />

immune resp<strong>on</strong>ses. Planta Medica, 1995, 61:45–49.<br />

60. Marinova EK et al. Suppressi<strong>on</strong> of experimental autoimmune tubulointerstitial<br />

nephritis in BALB/c mice by berberine. Immunopharmacology, 2000,<br />

48:9–16.<br />

61. Lampe KF. Berberine. In: De Smet PA et al. eds. Adverse effects of herbal<br />

d<strong>ru</strong>gs. Vol. 1. Berlin, Springer-Verlag, 1992:97–104.<br />

62. Lin HL et al. Up-regulati<strong>on</strong> of multid<strong>ru</strong>g resistance transporter expressi<strong>on</strong><br />

by berberine in human and murine hepatoma cells. Cancer, 1999, 85:1937–<br />

1942.<br />

63. Lin HL et al. Berberine modulates expressi<strong>on</strong> of mdr1 gene products and the<br />

resp<strong>on</strong>ses of digestive tract cancer cells to Paclitaxel. British Journal of Cancer,<br />

1999, 81:416–422.<br />

64. Wu XC, et al. Effects of berberine <strong>on</strong> the blood c<strong>on</strong>centrati<strong>on</strong> of cyclosporin<br />

A in renal transplant recipients: clinical and pharmacokinetic study. European<br />

Journal of Clinical Pharmacology, 2005, 61:567–572.<br />

65. Budzinski JW et al. An in vitro evaluati<strong>on</strong> of human cytochrome P450 3A4<br />

inhibiti<strong>on</strong> by <strong>selected</strong> commercial herbal extracts and tinctures. Phytomedicine,<br />

2000, 7:273–282.<br />

66. Morimoto I et al. Mutagenicity screening of c<strong>ru</strong>de d<strong>ru</strong>gs with Bacillus subtillus<br />

rec-assay and Salm<strong>on</strong>ella/microsome reversi<strong>on</strong> assay. Mutati<strong>on</strong> Research,<br />

1982, 97:81–102.<br />

67. Pasqual MS et al. Genotoxicity of the isoquinoline alkaloid berberine in<br />

prokaryotic and eukaryotic organisms. Mutati<strong>on</strong> Research, 1993, 286:243–252.<br />

68. Lee EB. [Teratogenicity of the extracts of c<strong>ru</strong>de d<strong>ru</strong>gs.] [ Korean Journal of<br />

Pharmacognosy], 1982, 13:116–121 [in Korean].<br />

257

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!